MT

Mogili Tejesh

Active Director Director DIN 09277851
DIN 09277851 First appointment Aug 2021 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Aug 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Mogili Tejesh

Data last updated:

Mogili Tejesh is a Director at Raphah Medicals And Surgicals Private Limited (since 2021) and Director at Vision Stem Private Limited (since 2021). The companies operate in Pharma and Healthcare.

DIN 09277851
Primary Designation Director
Industry Pharma
First Appointment 11 Aug 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director24 Dec 20212021Active
Vision Stem Private Limited U85100AP2021PTC119116
Director11 Aug 20212021Active

Board colleagues of Mogili Tejesh

Directorship timeline

Open interactive timeline →
Raphah Medicals And Surgicals Private Limited
Vision Stem Private Limited
Premium access

Shareholding and investment profile for Mogili Tejesh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mogili Tejesh

Mogili Tejesh currently holds 2 directorships: Raphah Medicals And Surgicals Private Limited (Director, since 24 Dec 2021); Vision Stem Private Limited (Director, since 11 Aug 2021).

Mogili Tejesh was first appointed on 11 Aug 2021 as Director at Vision Stem Private Limited.

The current boards of Mogili Tejesh's companies include Mahonneth Sesham (Raphah Medicals And Surgicals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available